Crocs chosen as approved footwear for diabetic patients; shares up ...

Tag : diabetic shoe
Shares of footwear retailer Crocs Inc. (Nasdaq: CROX ) are up 7% in pre-market trading today after the Center forMedicare and Medicaid Services accepted the company’s CustomCloud model into the diabetic shoe program. The Niwot, Colo.-basedcompany said acceptance into the program means doctors can fit themore than 23 million Americans with diabetes with the CrocsRxCustom Cloud model.
Also, after the close on Wednesday, competitor Skechers USA Inc. (NYSE: SKX ) denied allegations of patent and trade dress infringement ofCrocs’ logo. Skechers said the lawsuit is without merit andthat it is prepared to fight such claims.

In today’s pre-market trading, shares of Crocs are at $8.55at 9:04 a.m. ET , up $0.54 from Wednesday’s close.


---You can read the FULL article when you register (registration isfree!) or sign-in to SmallCapInvestor.com---